View in EDS HTML Full Text PDF Full Text

Epithelial-to-mesenchymal transition is an active process in the large airways of patients with asthma-COPD overlap and partially abrogated by inhaled corticosteroid treatment: a bronchoscopy endobronchial biopsy study.

Saved in:
Bibliographic Details
Title: Epithelial-to-mesenchymal transition is an active process in the large airways of patients with asthma-COPD overlap and partially abrogated by inhaled corticosteroid treatment: a bronchoscopy endobronchial biopsy study.
Authors: Dey S; Respiratory Translational Research Group, Department of Laboratory Medicine, School of Health Sciences, College of Health and Medicine, University of Tasmania, Launceston, TAS, Australia., Lu W; Respiratory Translational Research Group, Department of Laboratory Medicine, School of Health Sciences, College of Health and Medicine, University of Tasmania, Launceston, TAS, Australia., Pathinayake PS; Immune Health Program, Hunter Medical Research Institute, University of Newcastle, New Lambton Heights, Australia., Waters M; Department of Respiratory Medicine, Launceston General Hospital, Launceston, Australia., Haug G; Department of Respiratory Medicine, Launceston General Hospital, Launceston, Australia., Larby J; Department of Respiratory Medicine, Launceston General Hospital, Launceston, Australia., Weber HC; Department of Respiratory Medicine, Tasmanian Health Services (THS), North-West Hospital, Burnie, TAS, Australia., Wark PAB; Immune Health Program, Hunter Medical Research Institute, University of Newcastle, New Lambton Heights, Australia.; Department of Respiratory Medicine, Monash University, Melbourne, Australia., Eapen MS; Respiratory Translational Research Group, Department of Laboratory Medicine, School of Health Sciences, College of Health and Medicine, University of Tasmania, Launceston, TAS, Australia., Sohal SS; Respiratory Translational Research Group, Department of Laboratory Medicine, School of Health Sciences, College of Health and Medicine, University of Tasmania, Launceston, TAS, Australia.
Source: Frontiers in immunology [Front Immunol] 2025 May 22; Vol. 16, pp. 1531279. Date of Electronic Publication: 2025 May 22 (Print Publication: 2025).
Publication Type: Journal Article
Journal Info: Publisher: Frontiers Research Foundation] Country of Publication: Switzerland NLM ID: 101560960 Publication Model: eCollection Cited Medium: Internet ISSN: 1664-3224 (Electronic) Linking ISSN: 16643224 NLM ISO Abbreviation: Front Immunol Subsets: MEDLINE
Database: MEDLINE Ultimate
Full text is not displayed to guests.
FullText Links:
  – Type: pdflink
Text:
  Availability: 1
Header DbId: mdl
DbLabel: MEDLINE Ultimate
An: 40475784
AccessLevel: 2
PubType: Academic Journal
PubTypeId: academicJournal
PreciseRelevancyScore: 0
IllustrationInfo
Items – Name: Title
  Label: Title
  Group: Ti
  Data: Epithelial-to-mesenchymal transition is an active process in the large airways of patients with asthma-COPD overlap and partially abrogated by inhaled corticosteroid treatment: a bronchoscopy endobronchial biopsy study.
– Name: Author
  Label: Authors
  Group: Au
  Data: <searchLink fieldCode="AU" term="%22Dey+S%22">Dey S</searchLink>; Respiratory Translational Research Group, Department of Laboratory Medicine, School of Health Sciences, College of Health and Medicine, University of Tasmania, Launceston, TAS, Australia.<br /><searchLink fieldCode="AU" term="%22Lu+W%22">Lu W</searchLink>; Respiratory Translational Research Group, Department of Laboratory Medicine, School of Health Sciences, College of Health and Medicine, University of Tasmania, Launceston, TAS, Australia.<br /><searchLink fieldCode="AU" term="%22Pathinayake+PS%22">Pathinayake PS</searchLink>; Immune Health Program, Hunter Medical Research Institute, University of Newcastle, New Lambton Heights, Australia.<br /><searchLink fieldCode="AU" term="%22Waters+M%22">Waters M</searchLink>; Department of Respiratory Medicine, Launceston General Hospital, Launceston, Australia.<br /><searchLink fieldCode="AU" term="%22Haug+G%22">Haug G</searchLink>; Department of Respiratory Medicine, Launceston General Hospital, Launceston, Australia.<br /><searchLink fieldCode="AU" term="%22Larby+J%22">Larby J</searchLink>; Department of Respiratory Medicine, Launceston General Hospital, Launceston, Australia.<br /><searchLink fieldCode="AU" term="%22Weber+HC%22">Weber HC</searchLink>; Department of Respiratory Medicine, Tasmanian Health Services (THS), North-West Hospital, Burnie, TAS, Australia.<br /><searchLink fieldCode="AU" term="%22Wark+PAB%22">Wark PAB</searchLink>; Immune Health Program, Hunter Medical Research Institute, University of Newcastle, New Lambton Heights, Australia.; Department of Respiratory Medicine, Monash University, Melbourne, Australia.<br /><searchLink fieldCode="AU" term="%22Eapen+MS%22">Eapen MS</searchLink>; Respiratory Translational Research Group, Department of Laboratory Medicine, School of Health Sciences, College of Health and Medicine, University of Tasmania, Launceston, TAS, Australia.<br /><searchLink fieldCode="AU" term="%22Sohal+SS%22">Sohal SS</searchLink>; Respiratory Translational Research Group, Department of Laboratory Medicine, School of Health Sciences, College of Health and Medicine, University of Tasmania, Launceston, TAS, Australia.
– Name: TitleSource
  Label: Source
  Group: Src
  Data: <searchLink fieldCode="JN" term="%22101560960%22">Frontiers in immunology</searchLink> [Front Immunol] 2025 May 22; Vol. 16, pp. 1531279. <i>Date of Electronic Publication: </i>2025 May 22 (<i>Print Publication: </i>2025).
– Name: TypePub
  Label: Publication Type
  Group: TypPub
  Data: Journal Article
– Name: TitleSource
  Label: Journal Info
  Group: Src
  Data: <i>Publisher: </i><searchLink fieldCode="PB" term="%22Frontiers+Research+Foundation]%22">Frontiers Research Foundation] </searchLink><i>Country of Publication: </i>Switzerland <i>NLM ID: </i>101560960 <i>Publication Model: </i>eCollection <i>Cited Medium: </i>Internet <i>ISSN: </i>1664-3224 (Electronic) <i>Linking ISSN: </i><searchLink fieldCode="IS" term="%2216643224%22">16643224 </searchLink><i>NLM ISO Abbreviation: </i>Front Immunol <i>Subsets: </i>MEDLINE
PLink https://search.ebscohost.com/login.aspx?direct=true&site=eds-live&db=mdl&AN=40475784
RecordInfo BibRecord:
  BibEntity:
    Identifiers:
      – Type: doi
        Value: 10.3389/fimmu.2025.1531279
    Languages:
      – Code: eng
        Text: English
    PhysicalDescription:
      Pagination:
        StartPage: 1531279
    Titles:
      – TitleFull: Epithelial-to-mesenchymal transition is an active process in the large airways of patients with asthma-COPD overlap and partially abrogated by inhaled corticosteroid treatment: a bronchoscopy endobronchial biopsy study.
        Type: main
  BibRelationships:
    HasContributorRelationships:
      – PersonEntity:
          Name:
            NameFull: Dey S
      – PersonEntity:
          Name:
            NameFull: Lu W
      – PersonEntity:
          Name:
            NameFull: Pathinayake PS
      – PersonEntity:
          Name:
            NameFull: Waters M
      – PersonEntity:
          Name:
            NameFull: Haug G
      – PersonEntity:
          Name:
            NameFull: Larby J
      – PersonEntity:
          Name:
            NameFull: Weber HC
      – PersonEntity:
          Name:
            NameFull: Wark PAB
      – PersonEntity:
          Name:
            NameFull: Eapen MS
      – PersonEntity:
          Name:
            NameFull: Sohal SS
    IsPartOfRelationships:
      – BibEntity:
          Dates:
            – D: 22
              M: 05
              Text: 2025 May 22
              Type: published
              Y: 2025
          Identifiers:
            – Type: issn-electronic
              Value: 1664-3224
          Numbering:
            – Type: volume
              Value: 16
          Titles:
            – TitleFull: Frontiers in immunology
              Type: main
ResultId 1